Of note, CCNE1, CDK6 and E2F3 expression could serve as a prognostic marker of response to chemotherapy in NPM-ALK (+) ALCL patients and as a marker of response to CDK4/6 inhibition [42]. The gene discussed is CDK4; the disease is anaplastic large cell lymphoma.